Schizophrenia and related disorders

Essential Psychiatry, Fourth Edition

Volumn , Issue , 2008, Pages 284-319

  Murray, Robin M ^a   Dean, Kimberlie ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052162894     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544125.014     Document Type: Chapter

References (171)

1. Akbarian, S., Bunney, W E., Jr., Potkin, S. G., et al. (1993). Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 50:169-177.
2. Akbarian, S., Vinuela, A., Kim, J. J., et al. (1993). Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry 50:178-187.
3. Andreasen, N. C., & Carpenter, W. T., Jr. (1993). Diagnosis and classification of schizophrenia. Schizophr Bull 19:199-214.
4. Barta, P. E., Pearlson, G. D., Powers, R. E., et al. (1990). Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 147:1457-1462.
5. Bebbington, P., & Kuipers, L. (1994). The predictive utility of expressed emotion in schizophrenia: an aggregate analysis. Psychol Med 24:707-718.
6. Bebbington, P., Wilkins, S., Jones, P., etal. (1993). Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study. Br J Psychiatry 162:72-9.
7. Bentall, R. (2004). Madness Explained. Penguin Books
8. Blackwood, D. H., St Clair, D. M., Muir, W J., et al.(1991). Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. Arch Gen Psychiatry 48:899-909.
9. Bleuler, M. (1974). The long-term outcome of the schizophrenic psychoses. Psychol Med 4:244-254.
10. Boydell, J., van Os, J., Caspi, A., et al. (2006). Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999. Psychol Med 36:1441-1446.
11. Boydell, J., van Os, J., McKenzie, K., etal. (2001). Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment. BMJ 323:1336-1338.
12. Boyle, M. (2002). Schizophrenia: A Scientific Delusion? Hove: Routledge.
13. Bramon, E., McDonald, C., Croft, R. J., et al. (2005). Is the P300 wave an endophenotype for schizophrenia? A meta-analysis and a family study. Neuroimage, 27: 960-968.
14. Bramon, E., Walshe, M., McDonald, C., et al. (2005). Der- matoglyphics and schizophrenia: a meta-analysis and investigation of the impact of obstetric complications upon a-b ridge count. Schizophr Res 75:399-404.
15. Brockington, I. F. (1992). Schizophrenia: yesterday’s concept. Eur Psychiatry 7:203-7.
16. Brockington, I. F., Kendell, R. E., & Leff, J. P (1978). Definitions of schizophrenia: concordance and prediction of outcome. Psychol Med 8:387-398.
17. Brown, G. W., Birley, J. L., & Wing, J. K. (1972). Influence of family life on the course of schizophrenic disorders: a replication. Br J Psychiatry 121:241-258.
18. Brown, G. W., & Birley, J. L. T. (1968). Crises and life changes and the onset of schizophrenia. J Health SocBehav 9:203-214.
19. Burns, T., Creed, F., Fahy, T., et al. (1999). Intensive versus standard case management for severe psychotic illness: a randomised trial. UK 700 Group. Lancet 353: 2185-2189.
20. Busatto, G. F., Pilowsky, L. S., Costa, D. C., et al. (1997). Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia. Am J Psychiatry 154:56-63.
21. Cahn, W., van Haren, N. E., HulshoffPol, H. E., etal. (2006). Brain volume changes in the first year of illness and 5- year outcome of schizophrenia. Br J Psychiatry 189:381-382.
22. Cannon, M., Caspi, A., Moffitt, T. E., et al. (2002). Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry 59:449-456.
23. Cannon, M., Jones, P. B., & Murray, R. M. (2002). Obstetric complications and schizophrenia: historical and meta- analytic review. Am J Psychiatry 159:1080-1092.
24. Cannon, T. D., van Erp, T. G., Rosso, I. M., et al. (2002). Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry 59:35-41.
25. Cantor-Graae, E., & Selten, J. P (2005). Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry 162:12-24.
26. Cardno, A. G., Marshall, E. J., Coid, B., et al. (1999). Heri- tability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 56:162-168.
27. Carlsson, A., & Lindqvist, M. (1963). Effect of chlorpro- mazine or haloperidol on formation of 3methoxytyra- mine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 20:140-144.
28. Carpenter, W. T., Jr., Heinrichs, D. W, & Wagman, A. M. (1988). Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145:578-583.
29. Castle, D. J., & Murray, R. M. (1991). The neurodevelopmen- tal basis of sex differences in schizophrenia. Psychol Med 21:565-575.
30. Chen, C. K., Lin, S. K., Sham, P C., etal. (2005). Morbid risk for psychiatric disorder among the relatives of metham- phetamine users with and without psychosis. Am J Med GenetB Neuropsychiatr Genet 136:87-91.
31. Chen, C. K., Lin, S. K., Sham, P C., etal. (2003). Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med 33:1407-1414.
32. Chua, S., & Murray, R. M. (1995). The neurodevelopmental theory of schizophrenia: evidence concerning structure and neuropsychology. ActaNeuropsychiat., 7:568-570.
33. Claridge, G. (1972). The schizophrenias as nervous types. Br J Psychiatry 121:1-17.
34. Connell, P. H. (1958). Amphetamine Psychosis. London: Oxford University Press.
35. Cooper, J. E., Kendell, R. E., Gurland, B. J., et al. (1972). Psychiatric Diagnosis in New York and London. Oxford: Oxford University Press.
36. Craddock, M., Asherson, P, Owen, M. J., et al. (1996). Concurrent validity of the OPCRIT diagnostic system. Comparison of OPCRIT diagnoses with consensus best- estimate lifetime diagnoses. Br J Psychiatry 169:58-63.
37. Crow, T. J. (1980). Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry 137:383-386.
38. Crow, T. J. (1990). The continuum of psychosis and its genetic origins. The sixty-fifth Maudsley lecture. Br J Psychiatry 156:788-797.
39. Curran, C., Byrappa, N., & McBride, A. (2004). Stimulant psychosis: systematic review. Br J Psychiatry 185:196-204.
40. David, A. S., & Appleby, L. (1992). Diagnostic criteria in schizophrenia: accentuate the positive. Schizophr Bull, 18:551-557.
41. David, A. S., & Cutting, J. C. (1994). The Neuropsychology of Schizophrenia. East Sussex: Lawrence Erlbaum.
42. Davis, J. M., Chen, N., & Glick, I. D. (2003). A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 60:553-564.
43. Dazzan, P, Morgan, K. D., Orr, K., et al. (2005). Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology, 30:765-774.
44. Di Forti, M., Lappin, J. M., & Murray, R. M. (2007). Risk factors for schizophrenia - all roads lead to dopamine. European Neuropsychopharmacology, 17(Suppl 2):101- 107.
45. Enoch, M., & Ball, H. (2001). Uncommon Psychiatric Syndromes, 4th edn. London: Hodder & Stoughton.
46. Faris, R. E., & Dunham, W. (1939). Mental Disorders in Urban Areas: An Ecological Study of Schizophrenia and Other Psychoses. Chicago: University of Chicago Press.
47. Fearon, P., Kirkbride, J. B., Morgan, C., et al. (2006). Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med 36:1541-1550.
48. Fish, B., Marcus, J., Hans, S., Auerbach, J., & Perdue, S. (1992). Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect. Arch Gen Psychiatry 49:221-235.
49. Frith, C. (1992). The Cognitive Neuropsychology of Schizophrenia. Hove: Lawrence Erlbaum.
50. Garety, P. A., Kuipers, E., Fowler, D., et al. (2001). A cognitive model of the positive symptoms of psychosis. Psychol Med 31:189-195.
51. Goodman, L. A., Salyers, M. P., Mueser, K. T., et al. (2001). Recent victimization in women and men with severe mental illness: prevalence and correlates. J Trauma Stress 14:615-632.
52. Gottesman, I.I. (1991). Schizophrenia Genesis: The Origins of Madness. New York: Freeman.
53. Gray, J. A., Feldon, J., Rawlins, J. N. P., etal. (1991). The neuropsychology of schizophrenia. Behav Brain Sci 14:1-20.
54. Griffith, J. D., Cavanaugh, J., Held, J., et al. (1972). Dextroamphetamine. Evaluation of psychomimetic properties in man. Arch Gen Psychiatry 26:97-100.
55. Gupta, S., Sonnenberg, S. J., & Frank, B. (1998). Olanzapine augmentation of clozapine. Ann Clin Psychiatry 10:113-115.
56. Harding, C. M., Brooks, G. W., Ashikaga, T., etal. (1987). The Vermont longitudinal study of persons with severe mental illness, II: long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry 144:727-735.
57. Hare, E. (1983). Was insanity on the increase? The fifty-sixth Maudsley Lecture. Br J Psychiatry 142:439-455.
58. Harris, M. G., Henry, L. P, Harrigan, S. M., etal. (2005). The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophr Res 79:85-93.
59. Harrison, P. J., & Owen, M. J. (2003). Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361:417-419.
60. Henquet, C., Murray, R., Linszen, D., etal. (2005). The environment and schizophrenia: the role of cannabis use. Schizophr Bull 31:608-612.
61. Heston, L. L., & Denney, D. (1968). Interactions between early life experience and biological factors in schizophrenia. In D. Rosenthal & S. Kety, eds. The Transmission of Schizophrenia. Oxford, UK: Pergamon Press, pp. 363-376.
62. Hiday, V A., Swartz, M. S., Swanson, J. W., et al. (1999). Criminal victimization of persons with severe mental illness. Psychiatr Serv 50:62-68.
63. Hirsch, S. R., & Leff, J. (1975). Abnormalities in the Parents of Schizophrenics. Oxford: Oxford University Press.
64. Hoek, H. W., Brown, A. S., & Susser, E. (1998). The Dutch famine and schizophrenia spectrum disorders. Soc Psychiatry Psychiatr Epidemiol 33:373-379.
65. Hollister, J. M., Laing, P, & Mednick, S. A. (1996). Rhesus incompatibility as a risk factor for schizophrenia in male adults. Arch Gen Psychiatry 53:19-24.
66. Holzman, P S., Kringlen, E., Matthysse, S., et al. (1988). A single dominant gene can account for eye tracking dysfunctions and schizophrenia in offspring of discordant twins. Arch Gen Psychiatry 45:641-647.
67. Jablensky, A., Sartorius, N., Ernberg, G., et al. (1992). Schizophrenia: Manifestations, incidence and course in different cultures. A World Health Organisation ten country study. In Psychological Medicine Monograph Supplement 20. Cambridge: Cambridge University Press.
68. Janssen, I., Krabbendam, L., Bak, M., et al. (2004). Childhood abuse as a risk factor for psychotic experiences. Acta Psychiatr Scand 109:38-45.
69. Job, D. E., Whalley, H. C., Johnstone, E. C., etal. (2005). Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage 25:1023-1030.
70. Johnstone, E. C. (1994). Brain imaging, psychopathology and neurology. In H. Hafner & W. F. Gattaz, eds. Search for the Causes ofSchizophrenia. Berlin: Springer-Verlag, pp. 129-40.
71. Johnstone, E. C., Crow, T. J., Frith, C. D., etal. (1978). Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet 1:848-851.
72. Jones, P, Rodgers, B., Murray, R., etal. (1994). Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344:1398-1402.
73. Jones, P. B., Rantakallio, P, Hartikainen, A. L., et al. (1998). Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow- up of the 1966 north Finland general population birth cohort. Am J Psychiatry 155:355-364.
74. Kapur, S. (2003). Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160: 13-23.
75. Kasanin, J. (1933). The acute schizoaffective psychoses. Am J Psychiatry 13:97-123.
76. Kellendonk, C., Simpson, E. H., Polan, H. J., et al. (2006). Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49: 603-615.
77. Kendler, K. S. (1980). The nosologic validity of paranoia (simple delusional disorder). A review. Arch Gen Psychia- try 37:699-706.
78. Kendler, K. S., McGuire, M., Gruenberg, A. M., etal. (1993). The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch Gen Psychiatry 50:527-540.
79. Kety, S. S., Rosenthal, D., Wender, P. H., etal. (1975). Mental illness in the biological and adoptive families of adopted individuals who have become schizophrenic: a preliminary report based on psychiatric interviews. Proc Annu Meet Am Psychopathol Assoc 147-165.
80. Kirkbride, J. B., Fearon, P, Morgan, C., etal. (2007). Neighbourhood variation in the incidence of psychotic disorders in Southeast London. Soc Psychiatry Psychiatr Epi- demiol 42:438-445.
81. Kirkbride, J. B., Fearon, P., Morgan, C. (2006). Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry 63:250-258.
82. Kleist, K. (1930). Alogical thought disorder [Translated 1987]. In J. Cutting & M. Shepherd, eds. The Clinical Roots of the Schizophrenic Concept. Cambridge, UK: Cambridge University Press, pp. 75-79.
83. Kraepelin, E. (1919). Dementia Praecox and Paraphrenia. Translated by R. M. Barclay. Edinburgh: Livingstone.
84. Langfeldt, G. (1939). The Schizophreniform States. Oxford: Oxford University Press.
85. Laruelle, M., Abi-Dargham, A., van Dyck, C. H., et al. (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U SA 93:9235-9240.
86. Leff, J., Kuipers, L., Berkowitz, R., et al. (1982). A controlled trial of social intervention in the families of schizophrenic patients. Br J Psychiatry 141:121-134.
87. Lewis, G., David, A., Andreasson, S., et al. (1992). Schizophrenia and city life. Lancet 340:137-140.
88. Liddle, P. F. (1987). The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br J Psychiatry 151:145-151.
89. Lieberman, J. A., Stroup, T. S., McEvoy, J. P, et al. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353: 1209-1023.
90. Lieberman, J. A., Tollefson, G. D., Charles, C., et al. (2005). Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 62: 361-370.
91. Lishman, W. A. (1997). Organic Psychiatry: The Psychological Consequences of Cerebral Disorder, 3rd edn. Blackwell Science.
92. Marshall, M., & Lockwood, A. (2002). Assertive community treatment for people with severe mental disorders [Cochrane Review]. Oxford: Update Software, Cochrane Library.
93. Mata, I., Gilvarry, C. M., Jones, P B., etal. (2003). Schizotypal personality traits in nonpsychotic relatives are associated with positive symptoms in psychotic probands. SchizophrBull 29:273-283.
94. McGhie, A., & Chapman, J. (1961). Disorders of attention and perception in early schizophrenia. Br J Med Psychol 34:103-116.
95. McGorry, P D., Edwards, J., Mihalopoulos, C., etal. (1996). EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 22:305-326.
96. McGrath, J., Saha, S., Welham, J., etal. (2004). A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med 2:13.
97. McGrath, J. J., Pemberton, M. R., Welham, J. L., etal. (1994). Schizophrenia and the influenza epidemics of 1954:1957 and 1959: a southern hemisphere study. Schizophr Res 14:1-8.
98. McGrath, J. J., van Os, J., Hoyos, C., et al. (1995). Minor physical anomalies in psychoses: associations with clinical and putative aetiological variables. Schizophr Res 18:9-20.
99. McGuffin, P., Farmer, A. E., Gottesman, II, et al. (1984). Twin concordance for operationally defined schizophrenia. Confirmation of familiality and heritability. Arch Gen Psychiatry 41:541-545.
100. McGuire, P. K., Shah, G. M., & Murray, R. M. (1993). Increased blood flow in Broca’s area during auditory hallucinations in schizophrenia. Lancet 342:703-706.
101. McGuire, P. K., Silbersweig, D. A., Wright, I., et al. (1995). Abnormal monitoring of inner speech: a physiological basis for auditory hallucinations. Lancet 346: 596-600.
102. Mednick, S. A., Machon, R. A., Huttunen, M. O., etal. (1988). Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 45:189-192.
103. Mednick, S. A., Parnas, J., & Schulsinger, F. (1987). The Copenhagen High-Risk Project, 1962-86. Schizophr Bull 13:485-495.
104. Meltzer, H. Y., & Cola, P A. (1994). The pharmacoeconomics of clozapine: a review. J Clin Psychiatry 55(Suppl B):161- 165.
105. Morgan, C., & Fisher, H. (2007). Environment and schizophrenia: environmental factors in schizophrenia: childhood trauma - a critical review. Schizophr Bull 33:3-10.
106. Mortensen, P. B. (2003). Mortality and physical illness in schizophrenia. In R. M. Murray, P B. Jones, E. Susser, et al., eds. The Epidemiology of Schizophrenia. Cambridge: Cambridge University Press, pp. 275-287.
107. Mullen, P. E., & Lester, G. (2006). Vexatious litigants and unusually persistent complainants and petitioners: from querulous paranoia to querulous behaviour. Behav Sci Law 24:333-349.
108. Mullen, P. E., Martin, J. L., Anderson, J. C., et al. (1993). Childhood sexual abuse and mental health in adult life. Br J Psychiatry 163:721-732.
109. Munro, J. C., Russell, A. J., Murray, R. M., et al. (2002). IQ in childhood psychiatric attendees predicts outcome of later schizophrenia at 21 year follow-up. Acta Psychiatr Scand 106:139-142.
110. Murray, R. M. (1994). Neurodevelopmental schizophrenia: the rediscovery of dementia praecox. Br J Psychiatry Suppl November (25):6-12.
111. Murray, R. M., & Lewis, S. W. (1987). Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed) 295:681-682.
112. Murray, R. M., Sham, P., Van Os, J., et al. (2004). A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res 71:405-416.
113. Nayani, T. H., & David, A. S. (1995). The auditory hallucination: a phenomenological survey. Psychol Med 26:177-189.
114. National Institute for Clinical Excellence. (2006). Schizophrenia: Full National Clinical Guideline on Core Interventions in Primary and Secondary Care. London: Gaskell and the British Psychological Society.
115. O'Callaghan, E., Sham, P., Takei, N., et al. (1991). Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet 337:1248-1250.
116. Odegaard, O. (1932). Emigration and insanity: a study of mental disease among Norwegian-born population in Minnesota. Acta Psychiatr Neurol Scand Suppl 4:1-206.
117. Palmer, B. A., Pankratz, V S., & Bostwick, J. M. (2005). The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry 62:247-253.
118. Pantelis, C., Velakoulis, D., McGorry, P. D., et al. (2003). Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361:281-288.
119. Parnas, J., Schulsinger, F., Teasdale, T. W., et al. (1982). Perinatal complications and clinical outcome within the schizophrenia spectrum. Br J Psychiatry 140:416-420.
120. Pedersen, C. B., & Mortensen, P. B. (2001). Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Arch Gen Psychiatry 58:1039-1046.
121. Penn, D. L., Waldheter, E. J., Perkins, D. O., et al. (2005). Psychosocial treatment for first-episode psychosis: a research update. Am J Psychiatry 162:2220-2232.
122. Pilling, S., Bebbington, P., Kuipers, E., etal. (2002). Psychological treatments in schizophrenia: II. Meta-analyses of randomized controlled trials of social skills training and cognitive remediation. Psychol Med 32:783-791.
123. Pilling, S., Bebbington, P, Kuipers, E., et al. (2002). Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med 32:763-782.
124. Pilowsky, L., & Murray, R. M. (1991). Why don’t preschizophrenic children have delusions and hallucinations? Behav Brain Sci 41-42.
125. Pinfold, V, Toulmin, H., Thornicroft, G., et al. (2003). Reducing psychiatric stigma and discrimination: evaluation of educational interventions in UK secondary schools. Br J Psychiatry 182:342-346.
126. Pope, H. G., Jr., & Lipinski, J. F., Jr. (1978). Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of “schizophrenic” symptoms in the light of current research. Arch Gen Psychiatry 35:811-828.
127. Poulton, R., Caspi, A., Moffitt, T. E., et al. (2000). Children’s self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry 57:1053-1058.
128. Procci, W. R. (1976). Schizo-affective psychosis: fact or fiction? A survey of the literature. Arch Gen Psychiatry 33:1167-1178.
129. Read, J., & Argyle, N. (1999). Hallucinations, delusions, and thought disorder among adult psychiatric inpatients with a history of child abuse. Psychiatr Serv 50: 1467-1472.
130. Reveley, A. M., Reveley, M. A., Chitkara, B., etal. (1984). The genetic basis of cerebral ventricular volume. Psychiatry Res 13:261-266.
131. Reveley, A. M., Reveley, M. A., Clifford, C. A., et al. (1982). Cerebral ventricular size in twins discordant for schizophrenia. Lancet 1:540-541.
132. Ritchie, J. H., Dick, D., & Lingham, R. (1994). The Report of the Enquiry into the Care and Treatment of Christopher Clunis. London: HMSO.
133. Rosenhan, D. L. (1973). On being sane in insane places. Science 179:250-258.
134. Rosenheck, R., Leslie, D., Keefe, R., etal. (2006). Barriers to employment for people with schizophrenia. Am J Psychiatry 163:411-417.
135. Rosenthal, D., Wender, P H., Kety, S. S., et al. (1971). The adopted-away offspring of schizophrenics. Am J Psychiatry 128:307-311.
136. Sacker, A., Done, D. J., Crow, T. J., etal. (1995). Antecedents of schizophrenia and affective illness. Obstetric complications. Br J Psychiatry 166:734-741.
137. Schaefer, C.A., Brown, A. S., Wyatt, R. J., etal. (2000). Maternal prepregnant body mass and risk of schizophrenia in adult offspring. Schizophr Bull 26:275-286.
138. Schneider, K. (1950). Psychopathic Personalities (translated by M. Hamilton).
139. Scull, A. (1984). Was insanity increasing? A response to Edward Hare. Br J Psychiatry 144:432-436.
140. Sham, P. C., O'Callaghan, E., Takei, N., et al. (1992). Schizophrenia following pre-natal exposure to influenza epidemics between 1939 and 1960. Br J Psychiatry 160:461-466.
141. Shenton, M. E., Kikinis, R., Jolesz, F. A., etal. (1992). Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. NEngl JMed 327:604-612.
142. Shiloh, R., Zemishlany, Z., Aizenberg, D., et al. (1997). Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study. Br J Psychiatry 171:569-573.
143. Silver, E., Arseneault, L., Langley, J., etal. (2005). Mental disorder and violent victimization in a total birth cohort. Am J Public Health 95:2015-2021.
144. Slater, E., Beard, A. W., & Glithero, E. (1963). The schizophrenialike psychoses of epilepsy. Br J Psychiatry 109:95-150.
145. Spitzer, R. L., Endicott, J., & Robins, E. (1978). Research diagnostic criteria: rationale and reliability. Arch Gen Psy- chiatry 35:773-782.
146. Stefanis, N., Frangou, S., Yakeley, J., et al. (1999). Hippocampal volume reduction in schizophrenia: effects of genetic risk and pregnancy and birth complications. Biol Psychiatry 46:697-702.
147. Suddath, R. L., Christison, G. W, Torrey, E. F., et al. (1990). Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med 322:789-794.
148. Susser, E., Hoek, H. W., & Brown, A. (1998). Neurode- velopmental disorders after prenatal famine: The story of the Dutch Famine Study. Am J Epidemiol, 147:213-216.
149. Susser, E., & Wanderling, J. (1994). Epidemiology of non- affective acute remitting psychosis vs schizophrenia. Sex and sociocultural setting. Arch Gen Psychiatry 51:294-301.
150. Tienari, P, Wynne, L. C., Sorri, A., et al. (2004). Genotype- environment interaction in schizophrenia-spectrum disorder. Long-term follow-up study of Finnish adoptees. Br J Psychiatry 184:216-222.
151. Toulopoulou, T., Rabe-Hesketh, S., King, H., et al. (2003). Episodic memory in schizophrenic patients and their relatives. Schizophr Res 63:261-271.
152. Tsuang, M. T., Simpson, J. C., & Kronfol, Z. (1982). Subtypes of drug abuse with psychosis. Demographic characteristics, clinical features, and family history. Arch Gen Psychiatry 39:141-147.
153. Tsuang, M. T., Stone, W. S., & Faraone, S. V (2001). Genes, environment and schizophrenia. Br J Psychiatry Suppl, 40:18-24.
154. Tucker, C., Barker, A., & Gregoire, A. (1998). Living with schizophrenia: caring for a person with a severe mental illness. Soc Psychiatry Psychiatr Epidemiol 33: 305-309.
155. Turkington, D., Dudley, R., Warman, D. M., et al. (2004). Cognitive-behavioral therapy for schizophrenia: a review. J Psychiatr Pract 10:5-16.
156. van Os, J., Fahy, T. A., Jones, P., et al. (1995). Increased intracerebral cerebrospinal fluid spaces predict unemployment and negative symptoms in psychotic illness. A prospective study. Br J Psychiatry 166:750-758.
157. van Os, J., Fahy, T. A., Jones, P, et al. (1996). Psychopatho- logical syndromes in the functional psychoses: associations with course and outcome. Psychol Med 26:161-176.
158. Vaughan, C., & Leff, J. (1976). The influence of family and social factors on the course of psychiatric illness. Br J Psychiatry 125-137.
159. Velakoulis, D., Wood, S. J., Wong, M. T., et al. (2006). Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry 63:139-149.
160. Wahlbeck, K., Forsen, T., Osmond, C., et al. (2001). Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood. Arch Gen Psychiatry 58:48-52.
161. Walker, E., & Lewine, R. J. (1990). Prediction of adult- onset schizophrenia from childhood home movies of the patients. Am J Psychiatry 147:1052-1056.
162. Weinberger, D. R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669.
163. Wessely, S., Castle, D., Der, G., et al. (1991). Schizophrenia and Afro-Caribbeans. A case-control study. Br J Psychiatry 159:795-801.
164. Wing, J. K., & Brown, G. W. (1970). Institutionalism and Schizophrenia. Cambridge: Cambridge University Press.
165. Wing, J. K., Cooper, J. E., & Sartorius, N. (1974). The Description and Classification of Psychiatric Symptoms: An Instruction Manual for the PSE and CATEGO System. London: Cambridge University Press.
166. Wing, J. K. (1978). Clinical concepts of schizophrenia. In: J. K. Wing, ed. Schizophrenia Towards a New Synthesis. London: Academic Press.
167. World Health Organisation (1973). Report of the International Pilot Study of Schizophrenia. Geneva: World Health Organisation.
168. World Health Organisation (1992). International Classification of Impairments, Disabilities and Handicaps, 10th revision. Geneva: World Health Organisation.
169. Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W., etal. (2000). Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157:16-25.
170. Wykes, T., & Reeder, C. (2005). Cognitive Remediation Therapy: Theory and Practice. London: Brunner Routledge.
171. Ziedonis, D. M., Smelson, D., Rosenthal, R. N., etal. (2005). Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatr Pract, 11:315-339.